| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/05/2007 | WO2007009986A3 Process for obtaining a composite |
| 04/05/2007 | WO2007009806A3 Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| 04/05/2007 | WO2007006939A3 Thermoreversible immuno-adjuvant emulsion |
| 04/05/2007 | WO2007005754A3 Liposomal delivery vehicle for hydrophobic drugs |
| 04/05/2007 | WO2007002315A3 Nanoparticulate megestrol formulations |
| 04/05/2007 | WO2006135480A3 Oral pharmaceutical formulations comprising fenofibric acid and/or its salts |
| 04/05/2007 | WO2006130455A3 Bioresorbable polymer matrices and methods of making and using the same |
| 04/05/2007 | WO2006128039A3 Fluid delivery device having an electrochemical pump with an ion-exchange membrane and associated method |
| 04/05/2007 | WO2006128022A3 Solid compositions and methods for treating middle-of-the night insomnia |
| 04/05/2007 | WO2006127740A3 Indicia-bearing package for delivery systems for managing release of sweeteners, sensates, functional ingredients, food acids and flavors in a compressible gum system |
| 04/05/2007 | WO2006113568A3 Controlled delivery dosage form of tramadol and gabapentin |
| 04/05/2007 | WO2006108405B1 Nanoparticle/active ingredient conjugate |
| 04/05/2007 | WO2006100075A3 Use of an artificial sweetener to enhance absorption of nicotine |
| 04/05/2007 | WO2006086428A3 Particles for inactivating toxins |
| 04/05/2007 | WO2006084793A3 Film-coated tablets containing ibuprofen lysinate |
| 04/05/2007 | WO2006037979A3 Nanoparticles comprising antigens and adjuvants and immunogenic structure |
| 04/05/2007 | WO2006032039A3 Compositions and their uses for lysosomal enzyme deficiencies |
| 04/05/2007 | WO2006030030A3 System for the sequential, transdermal administration of systemically active substances |
| 04/05/2007 | WO2006024638A3 Peroral dosage forms to achieve a sustained-release effect after medicament dosage with a meal |
| 04/05/2007 | WO2006014886A3 Calcium phosphate cements and methods for using the same |
| 04/05/2007 | WO2005101466A3 Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography |
| 04/05/2007 | WO2005086694A3 Occlusive biomedical devices, punctum plugs, and methods of use thereof |
| 04/05/2007 | US20070078522 Particulate Acellular Tissue Matrix |
| 04/05/2007 | US20070078445 Synchronization apparatus and method for iontophoresis device to deliver active agents to biological interfaces |
| 04/05/2007 | US20070078119 Storage system for texaphyrin pharmaceutical formulations |
| 04/05/2007 | US20070078106 A 5-substituted uracil or 5,6-dihydro-5-substituted uracil, potentiate 5-fluorouracil; 5-substituent is selected from bromo, ido, cyano, halo-substituted C1-4 alkyl, C2-6 alkenyl, 1-halo-C2-6 alkenyl andhalo-substituted C2-6 alkynyl; antitumor agents; anticarcinogenic agents |
| 04/05/2007 | US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents |
| 04/05/2007 | US20070078103 Formulations comprising antisense nucleotides to connexins |
| 04/05/2007 | US20070078096 Buffered drug formulations for transdermal electrotransport delivery |
| 04/05/2007 | US20070078084 Compositions and methods related to production of erythropoietin |
| 04/05/2007 | US20070078076 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 04/05/2007 | US20070077432 Finely particulate composite containing carbon compound encapsulated therein |
| 04/05/2007 | US20070077309 Banded controlled release nanoparticle active agent formulation dosage forms and methods |
| 04/05/2007 | US20070077308 Continuous multi-microencapsulation process for improving the stability and storage life of biologically active ingredients |
| 04/05/2007 | US20070077307 Pharmaceutical compositions |
| 04/05/2007 | US20070077306 Apatite particle, method of producing the same, apatite particle-gene complex, and method of gene transfection |
| 04/05/2007 | US20070077305 Biocompatible polymeric matrix and preparation thereof |
| 04/05/2007 | US20070077304 Sustained Release Small Molecule Drug Formulation |
| 04/05/2007 | US20070077303 Methods for providing oxidatively stable ophthalmic compositions |
| 04/05/2007 | US20070077302 Methods for stabilizing ophthalmic compositions |
| 04/05/2007 | US20070077301 Venlafaxine osmotic device formulation |
| 04/05/2007 | US20070077300 Oral compositions containing a salivation inducing agent |
| 04/05/2007 | US20070077299 Oral formulation for 5-ht-receptor agonists, uses and methods of treatment employing the same |
| 04/05/2007 | US20070077298 ring-opening polymerization of epoxidized vegetable oils, followed by chemical hydrolysis; renewable polymer; use as food additives and in drug delivery system |
| 04/05/2007 | US20070077297 Modified release ibuprofen dosage form |
| 04/05/2007 | US20070077296 Pharmaceutical Preparation containing Meloxicam |
| 04/05/2007 | US20070077295 Method and composition for pharmaceutical product |
| 04/05/2007 | US20070077294 Capsules comprising topiramate |
| 04/05/2007 | US20070077293 Film-forming composition suitable for hard capsules and method for preparing the same |
| 04/05/2007 | US20070077292 Compositions and methods for improved skin care |
| 04/05/2007 | US20070077291 Drug delivery nanocarriers targeted by landscape phage |
| 04/05/2007 | US20070077290 High delivery rates for lipid based drug formulations, and methods of treatment thereof |
| 04/05/2007 | US20070077289 Cream containing interferon encapsulated with liposome |
| 04/05/2007 | US20070077288 Transdermal delivery of non-steroidal anti-inflammatory drugs |
| 04/05/2007 | US20070077287 Transdermal art patch |
| 04/05/2007 | US20070077286 Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle |
| 04/05/2007 | US20070077285 Adhesive skin patch |
| 04/05/2007 | US20070077284 Transdermal formulation comprising an opioid analgesic and an aloe composition |
| 04/05/2007 | US20070077282 Adhesive patch for external use on skin |
| 04/05/2007 | US20070077281 Medical skin patches with a content of essential oils for treating colds, and processes for their production |
| 04/05/2007 | US20070077279 Novel compositions containing polyphenols |
| 04/05/2007 | US20070077278 Polysaccharide-containing composition and tear film stabilizing ophthalmic solution |
| 04/05/2007 | US20070077277 Compositions and uses thereof |
| 04/05/2007 | US20070077276 Multilayer films, coatings, and microcapsules comprising polypeptides |
| 04/05/2007 | US20070077275 Thin film comprising plurality of peptide layers for use in biomedicine |
| 04/05/2007 | US20070077273 Microfabricated nanopore device for sustained release of therapeutic agent |
| 04/05/2007 | US20070077261 Compositions and method for enhancing the solubility of ascorbic acid using solubilization enhancers |
| 04/05/2007 | US20070077259 Polylysine positively charged backbone, oligoarginine branching group, hydroxypropylcellulose viscosity modifying agent; treat wrinkles, hyperhidrosis, neurologic pain, migraine headache, reducing muscle spasms, preventing or reducing acne; reduced training necessary for applying botulinum therapeutic |
| 04/05/2007 | US20070077258 ADMINISTRATION OF GLUTATHIONE (REDUCED) VIA INTRAVENOUS OR ENCAPSULATED IN LIPOSOME FOR THE AMELIORATION OF TNF-alpha EFFECTS AND FLU-LIKE VIRAL SYMPTOMS AND TREATMENT AND PREVENTION OF VIRUS |
| 04/05/2007 | US20070077253 Multilayer thin film comprising two or more adjacent layers of oppositely charged polyelectrolytes and encapsulated antigenic peptides; vaccine development |
| 04/05/2007 | US20070077232 Conditioned cell culture medium compositions and methods of use |
| 04/05/2007 | US20070077230 Method for the pre-conditioning/fixation and treatment of diseases with heat activation/release with thermo-activated drugs and gene products |
| 04/05/2007 | US20070077229 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin |
| 04/05/2007 | US20070077210 cyclodextrins |
| 04/05/2007 | US20070077209 Stabilized particle dispersions containing nanoparticles |
| 04/05/2007 | US20070077208 Pharmaceutical foam |
| 04/05/2007 | US20070077207 Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
| 04/05/2007 | US20070074362 Disposable liquid absorbing cleaning pad for a hand held cleaning implement having an elongated handle |
| 04/05/2007 | CA2850858A1 Compositions and methods for the intraocular transport of therapeutic agents |
| 04/05/2007 | CA2762013A1 Granulation of pirfenidone and pharmaceutically acceptable excipients |
| 04/05/2007 | CA2637365A1 Injectable viscous medicinal preparation comprising ethanol and an x-ray opaque fat-soluble compound |
| 04/05/2007 | CA2624494A1 Orodispersible tablets of bitter active principles |
| 04/05/2007 | CA2624372A1 Microparticles with modified release of at least one active principle and oral galenic form comprising same |
| 04/05/2007 | CA2624356A1 Skincare products |
| 04/05/2007 | CA2624112A1 Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom |
| 04/05/2007 | CA2623968A1 Method for stabilising pharmaceutical administration forms comprising microorganisms |
| 04/05/2007 | CA2623882A1 Aerosol powder formulation comprising sieved lactose |
| 04/05/2007 | CA2623429A1 Interleukin-13 antibody composition |
| 04/05/2007 | CA2622753A1 Effervescent oral care compositions and methods of use |
| 04/05/2007 | CA2622475A1 Treatment of inflammation and vascular abnormalities of the eye |
| 04/05/2007 | CA2621597A1 In vivo formed matrices including natural biodegradable polysaccharides and ophthalmic uses thereof |
| 04/05/2007 | CA2618068A1 Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| 04/05/2007 | CA2609618A1 Novel acetylsalicylic acid formulations |
| 04/04/2007 | EP1769821A1 Applicator for the delivery of topical formulations into mucosal cavities |
| 04/04/2007 | EP1769819A2 Metered dose inhaler for fluticasone propionate |
| 04/04/2007 | EP1769804A2 Method of increasing bone toughness and stiffness and reducing fractures |
| 04/04/2007 | EP1769790A1 Preparations for the intranasal application of selected CGRP antagonists derived from amino acids |
| 04/04/2007 | EP1769785A1 Dermal penetration enhancers and drug delivery systems involving same |
| 04/04/2007 | EP1769773A1 Dental device with improved retention of a flavor and/or chemotherapeutic agent composition |
| 04/04/2007 | EP1768692A2 Targeted and high density drug loaded polymeric materials |